Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $151.18M.
ENTERPRISE VALUE (EV)
$151.18M
Compass Therapeutics, Inc.
Market Cap
$172.99M
Enterprise Value (EV)
$151.18M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | $172.99M | $151.18M |
| Coherus Oncology, Inc. (CHRS)vs › | $173.04M | $127.82M |
| Precision BioSciences, Inc. (DTIL)vs › | $174.17M | $116.19M |
| Cue Biopharma, Inc. (CUE)vs › | $176.96M | $168.38M |
| Canton Strategic Holdings Inc (CNTN)vs › | $179.70M | $142.45M |
| ALX Oncology Holdings Inc. (ALXO)vs › | $162.82M | $149.84M |
| Journey Medical Corporation (DERM)vs › | $184.12M | $184.02M |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $153.84M | $125.97M |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $192.97M | $186.63M |
| Anavex Life Sciences Corp. (AVXL)vs › | $152.45M | $34.12M |
Market Cap
$172.99M
Total Debt
$8.83M
Cash
$30.64M
Enterprise Value
$151.18M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
